Literature DB >> 27729270

Serum osteopontin is a biomarker of severe fibrosis and portal hypertension in human and murine schistosomiasis mansoni.

Thiago Almeida Pereira1, Wing-Kin Syn2, Fausto E L Pereira3, José Roberto Lambertucci4, William Evan Secor5, Anna Mae Diehl6.   

Abstract

Schistosomiasis is a major cause of fibrosis and portal hypertension. The reason 4-10% of infected subjects develops hepatosplenic schistosomiasis remains unclear. Chronically infected male CBA/J mice reproduce the dichotomic forms of human schistosomiasis. Most mice (80%) develop moderate splenomegaly syndrome (similar to hepatointestinal disease in humans) and 20% present severe hypersplenomegaly syndrome (analogous to human hepatosplenic disease). We demonstrated that the profibrogenic molecule osteopontin discriminates between mice with severe and mild disease and could be a novel morbidity biomarker in murine and human schistosomiasis. Failure to downregulate osteopontin during the chronic phase may explain why hepatosplenic subjects develop severe fibrosis. Copyright Â
© 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Biomarker; Liver fibrosis; Osteopontin; Portal hypertension; Schistosomiasis mansoni

Mesh:

Substances:

Year:  2016        PMID: 27729270      PMCID: PMC5584370          DOI: 10.1016/j.ijpara.2016.08.004

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  25 in total

1.  Identification of an IL-27/osteopontin axis in dendritic cells and its modulation by IFN-gamma limits IL-17-mediated autoimmune inflammation.

Authors:  Gopal Murugaiyan; Akanksha Mittal; Howard L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

Review 2.  Hedgehog signaling in the liver.

Authors:  Alessia Omenetti; Steve Choi; Gregory Michelotti; Anna Mae Diehl
Journal:  J Hepatol       Date:  2010-10-14       Impact factor: 25.083

3.  IL-10 deficit correlates with chronic, hypersplenomegaly syndrome in male CBA/J mice infected with Schistosoma mansoni.

Authors:  S C Bosshardt; G L Freeman; W E Secor; D G Colley
Journal:  Parasite Immunol       Date:  1997-08       Impact factor: 2.280

4.  Immune responses and immunoregulation in relation to human schistosomiasis in Egypt. III. Immunity and longitudinal studies of in vitro responsiveness after treatment.

Authors:  D G Colley; I S Barsoum; H S Dahawi; F Gamil; M Habib; M A el Alamy
Journal:  Trans R Soc Trop Med Hyg       Date:  1986       Impact factor: 2.184

5.  Gamma-interferon treatment inhibits collagen deposition in murine schistosomiasis.

Authors:  M J Czaja; F R Weiner; S Takahashi; M A Giambrone; P H van der Meide; H Schellekens; L Biempica; M A Zern
Journal:  Hepatology       Date:  1989-11       Impact factor: 17.425

Review 6.  Induction and regulation of pathogenic Th17 cell responses in schistosomiasis.

Authors:  Bridget M Larkin; Patrick M Smith; Holly E Ponichtera; Mara G Shainheit; Laura I Rutitzky; Miguel J Stadecker
Journal:  Semin Immunopathol       Date:  2012-10-25       Impact factor: 9.623

Review 7.  Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection.

Authors:  Iramaya Rodrigues Caldas; Ana Carolina Campi-Azevedo; Lucia Fraga Alves Oliveira; Alda Maria Soares Silveira; Rodrigo C Oliveira; Giovanni Gazzinelli
Journal:  Acta Trop       Date:  2008-06-05       Impact factor: 3.112

Review 8.  Schistosomiasis and liver fibrosis.

Authors:  Z A Andrade
Journal:  Parasite Immunol       Date:  2009-11       Impact factor: 2.280

9.  Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis.

Authors:  Wing-Kin Syn; Steve S Choi; Evaggelia Liaskou; Gamze F Karaca; Kolade M Agboola; Ye Htun Oo; Zhiyong Mi; Thiago A Pereira; Marzena Zdanowicz; Padmini Malladi; Yuping Chen; Cynthia Moylan; Youngmi Jung; Syamal D Bhattacharya; Vanessa Teaberry; Alessia Omenetti; Manal F Abdelmalek; Cynthia D Guy; David H Adams; Paul C Kuo; Gregory A Michelotti; Peter F Whitington; Anna Mae Diehl
Journal:  Hepatology       Date:  2010-10-21       Impact factor: 17.425

10.  Neonatal idiotypic exposure alters subsequent cytokine, pathology, and survival patterns in experimental Schistosoma mansoni infections.

Authors:  M A Montesano; D G Colley; S Eloi-Santos; G L Freeman; W E Secor
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

View more
  3 in total

1.  Serum osteopontin is a predictor of prognosis for HBV-associated acute-on-chronic liver failure.

Authors:  Longgen Liu; Jianchun Lu; Chunyan Ye; Lin Lin; Shuqin Zheng; Hongyu Zhang; Qing Lan; Yuan Xue
Journal:  Biomed Rep       Date:  2017-12-13

2.  Microfibrillar-associated protein 4 variation in symptomatic peripheral artery disease.

Authors:  Line Ea Hemstra; Anders Schlosser; Jes Sanddal Lindholt; Grith L Sorensen
Journal:  J Transl Med       Date:  2018-06-08       Impact factor: 5.531

Review 3.  The Genetics of Human Schistosomiasis Infection Intensity and Liver Disease: A Review.

Authors:  Estelle M Mewamba; Oscar A Nyangiri; Harry A Noyes; Moses Egesa; Enock Matovu; Gustave Simo
Journal:  Front Immunol       Date:  2021-02-15       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.